| Issue |
Med Sci (Paris)
Volume 36, Number 1, Janvier 2020
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 83 - 86 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2019263 | |
| Published online | 04 February 2020 | |
Des néo-antigènes non mutés, les TEIPP, comme nouvelles cibles des immunothérapies du cancer
Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies
1
Master 1 cancer, module d’immunologie-virologie, université de Lyon, université Claude Bernard Lyon 1, Lyon, France
2
UMR Inserm 1052, CNRS 5286, centre Léon Bérard, centre de recherche en cancérologie de Lyon, 28 rue Laennec 69373 Lyon cedex 08, France
* adrien.vouilloz@etu.univ-lyon1.fr
** laurent.serre@gmail.com
Cet article ne possède pas de résumé.
© 2020 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
